Related Experiment Video
Updated: Jul 10, 2026

12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
[SIMBO: a Screening Instrument for Identification of Work-Related Disabilities--analyses of construct and prognostic
M Streibelt1, H Gerwinn, T Hansmeier
1Charité--Universitätsmedizin, Abteilung für Versorgungssystemforschung und Qualitätssicherung in der medizinischen Rehabilitation, Berlin. marco.streibelt@charite.de
Die Rehabilitation
|October 24, 2007
Summary
The Screening Instrument for Identification of a Demand for Medical-Vocational Oriented Rehabilitation (SIMBO) effectively identifies patients needing vocational rehabilitation. SIMBO accurately predicts work-related challenges and successful return to work.
Area of Science:
- Medical rehabilitation
- Occupational health
- Vocational assessment
Context:
- Work-related interventions in medical rehabilitation (MBO) focus on vocational problems linked to health and environmental factors.
- Accurate identification of specific demands is crucial for successful MBO interventions.
- Existing instruments for identifying occupational challenges are lacking.
Purpose:
- To introduce the Screening Instrument for Identification of a Demand for Medical-Vocational Oriented Rehabilitation (SIMBO).
- To evaluate the clinical and predictive validity of SIMBO in identifying the need for MBO.
- To assess SIMBO's utility for social insurance agencies.
Summary:
- SIMBO demonstrated agreement with clinical MBO demand identification in 74-78% of cases (r=0.59).
- SIMBO accurately predicted expected work-related problems (77%, r=0.50) and return to work (RTW) in good health (77%).
- SIMBO's predictive accuracy for work-related problems surpassed external ratings by insurance staff.
Impact:
- SIMBO is a valid and easy-to-use tool for identifying the need for vocationally-focused interventions.
- The instrument aids social insurance agencies in financing rehabilitation.
- Further research is warranted for SIMBO's application across different indications and as an outcome measure.
